Orthofix Medical Inc. Provision for Loan and Lease Losses
Orthofix Medical Inc. (OFIX) reported Provision for Loan and Lease Losses of $1.38 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Notes › Credit Losses
us-gaap:ProvisionForLoanAndLeaseLosses · last filed 2024-05-07
- Orthofix Medical Inc. provision for loan and lease losses for the quarter ending 2024-03-31 was $1.38M, a 561.54% increase year-over-year.
- Orthofix Medical Inc. provision for loan and lease losses for the quarter ending 2023-12-31 was -$85.00K, a 122.25% decline year-over-year.
- Orthofix Medical Inc. provision for loan and lease losses for the quarter ending 2023-09-30 was $415.00K, a 27.70% decline year-over-year.
- Orthofix Medical Inc. provision for loan and lease losses for the quarter ending 2023-06-30 was $282.00K, a 47.68% decline year-over-year.
- Orthofix Medical Inc. provision for loan and lease losses for fiscal 2023 was $820.00K, a 60.86% decline from fiscal 2022.
- Orthofix Medical Inc. provision for loan and lease losses for fiscal 2022 was $2.10M, a 371.85% increase from fiscal 2021.
- Orthofix Medical Inc. provision for loan and lease losses for fiscal 2021 was $444.00K.
| Period end | Provision for Loan and Lease Losses 3 month | Provision for Loan and Lease Losses 6 month | Provision for Loan and Lease Losses 9 month | Provision for Loan and Lease Losses 12 month |
|---|---|---|---|---|
| 2024-03-31 | $1.38M 10-Q · filed 2024-05-07 | $1.29M derived: sum of 2 quarters · filed 2024-05-07 | $1.71M derived: sum of 3 quarters · filed 2024-05-07 | $1.99M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | -$85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $330.00K derived: sum of 2 quarters · filed 2024-03-05 | $612.00K derived: sum of 3 quarters · filed 2024-03-05 | $820.00K 10-K · filed 2024-03-05 |
| 2023-09-30 | $415.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $697.00K derived: sum of 2 quarters · filed 2023-11-08 | $905.00K 10-Q · filed 2023-11-08 | $1.29M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-06-30 | $282.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $490.00K 10-Q · filed 2023-08-08 | $872.00K derived: sum of 3 quarters · filed 2024-05-07 | $1.45M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-03-31 | $208.00K 10-Q · filed 2024-05-07 | $590.00K derived: sum of 2 quarters · filed 2024-05-07 | $1.16M derived: sum of 3 quarters · filed 2024-05-07 | $1.70M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $382.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $956.00K derived: sum of 2 quarters · filed 2024-03-05 | $1.50M derived: sum of 3 quarters · filed 2024-03-05 | $2.10M 10-K · filed 2024-03-05 |
| 2022-09-30 | $574.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.11M derived: sum of 2 quarters · filed 2023-11-08 | $1.71M 10-Q · filed 2023-11-08 | $1.78M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $539.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.14M 10-Q · filed 2023-08-08 | $1.21M derived: sum of 3 quarters · filed 2024-03-05 | $1.80M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $600.00K 10-Q · filed 2023-05-09 | $668.00K derived: sum of 2 quarters · filed 2024-03-05 | $1.26M derived: sum of 3 quarters · filed 2024-03-05 | $1.23M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $658.00K derived: sum of 2 quarters · filed 2024-03-05 | $626.00K derived: sum of 3 quarters · filed 2024-03-05 | $444.00K 10-K · filed 2024-03-05 |
| 2021-09-30 | $590.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $558.00K derived: sum of 2 quarters · filed 2022-11-03 | $376.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$214.00K 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | -$182.00K 10-Q · filed 2022-05-06 | |||
| 2020-09-30 | -$619.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $266.00K derived: sum of 2 quarters · filed 2021-11-05 | $945.00K 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $885.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $1.56M 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | $679.00K 10-Q · filed 2021-04-30 | |||
| 2019-09-30 | $223.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $815.00K derived: sum of 2 quarters · filed 2020-11-05 | $861.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $592.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $638.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $46.00K 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |